Persistent small afferent input generated by tissue injury yields a facilitated state of nociceptive processing. The associated pain behavior is blocked by spinal delivery of agonists for Gi/o protein coupled receptors, such as 5 opiates. Analgesic efficacy occurs in part by a presynaptic inhibition of small afferent (e.g. substance P, sP). Continued intrathecal (IT) infusion of 5 opiates results in a loss of analgesic potency and a concurrent loss of suppression of sP. Enabling data suggest that with tissue injury and chronic opiate exposure the evolution of the hyperalgesic state and loss of efficacy reflects upon activation of links which involve the spinal Akt signaling cascade. These studies will undertake the following: 1. Determine expression and phosphorylation of Akt and its downstream substrates, specifically, GSK32, mTOR in spinal dorsal horn and DRG in control and in evocative pain states over time in rat after local tissue injury (Intraplantar formalin, intraplantar carrageenan) and in mice with KBxN serum-induced arthritis. 2. Define cellular localization of pAkt, pGSK3 and pmTOR in spinal DRG and dorsal horn in control animals and after peripheral inflammation. 3. Determine change in phosphorylation state of dorsal horn Akt, GSK/2 and mTOR after intraplantar formalin with the acute spinal delivery of: i) 5 agonist;ii) blockers of NK1, glutamatergic ionotropic or metabotrophic excitatory receptors. 4. Define role of the spinal Akt cascade in pain processing by examining the effects of IT inhibitors of Akt, GSK32 or mTOR in models of hyperalgesia in rat: i) acute flinching and chronic tactile allodynia after intraplantar formalin, ii) tactile allodynia and thermal hyperalgesia after intraplantar carrageenan and iii) the centrally initiated thermal hyperalgesia after IT delivery of agonists for NK1 and group I mGlu receptors;and with IP drug delivery in the mouse model of KBxN arthritis. 5. Examine role of the spinal Akt cascade in spinal opioid tolerance and dependence produced by chronic IT morphine infusion and during the withdrawal produced by antagonism of the respective receptor (e.g. naloxone), wherein the respective enzyme inhibitor is co-infused with opiate agonist. These studies will accordingly define the role of this Akt cascade in pain and opiate tolerance.

Public Health Relevance

Hyperalgesia after injury or inflammation involves spinal signaling links, one of which we hypothesize is the Akt cascade. Akt may also mediate opioid tolerance. Our work thus targets this link for these two critical issues in pain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002110-33
Application #
8429475
Study Section
Somatosensory and Chemosensory Systems Study Section (SCS)
Program Officer
Rapaka, Rao
Project Start
1983-07-01
Project End
2015-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
33
Fiscal Year
2013
Total Cost
$287,741
Indirect Cost
$101,501
Name
University of California San Diego
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Marino, Marc J; Terashima, Tetsuji; Steinauer, Joanne J et al. (2014) Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior. Pain 155:674-84
Park, Hue Jung; Stokes, Jennifer A; Corr, Maripat et al. (2014) Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice. Cancer Chemother Pharmacol 73:25-34
Gregus, Ann M; Dumlao, Darren S; Wei, Spencer C et al. (2013) Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia. FASEB J 27:1939-49
Park, Hue Jung; Stokes, Jennifer A; Pirie, Elaine et al. (2013) Persistent hyperalgesia in the cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etanercept. Anesth Analg 116:224-31
Takasusuki, Toshifumi; Yamaguchi, Shigeki; Hamaguchi, Shinsuke et al. (2013) Effects of general anesthetics on substance P release and c-Fos expression in the spinal dorsal horn. Anesthesiology 119:433-42
Stokes, Jennifer A; Corr, Maripat; Yaksh, Tony L (2013) Spinal toll-like receptor signaling and nociceptive processing: regulatory balance between TIRAP and TRIF cascades mediated by TNF and IFN?. Pain 154:733-42
Terashima, Tetsuji; Xu, Qinghao; Yamaguchi, Shigeki et al. (2013) Intrathecal P/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression. Neuropharmacology 75:1-8
Wahlert, Andrew; Funkelstein, Lydiane; Fitzsimmons, Bethany et al. (2013) Spinal astrocytes produce and secrete dynorphin neuropeptides. Neuropeptides 47:109-15
Kouchek, Milad; Takasusuki, Toshifumi; Terashima, Tetsuji et al. (2013) Effects of intrathecal SNC80, a delta receptor ligand, on nociceptive threshold and dorsal horn substance p release. J Pharmacol Exp Ther 347:258-64
Hamurtekin, Emre; Fitzsimmons, Bethany L; Shubayev, Veronica I et al. (2013) Evaluation of spinal toxicity and long-term spinal reflex function after intrathecal levobupivaciane in the neonatal rat. Anesthesiology 119:142-55

Showing the most recent 10 out of 92 publications